JCOIN Webinar | Treatment Considerations in the Age of Fentanyl
Fentanyl and other high potency synthetic opioids are increasingly present in the U.S. drug supply. Healthcare systems, treatment providers and justice systems are grappling with the physiological consequences of chronic fentanyl use and how its use may impact treatment.
Presenters discussed practical clinical practice-based guidance on treating opioid use disorder in the age of fentanyl, the use of medications for opioid use disorder (MOUD) in the treatment of individuals using fentanyl and other considerations and challenges. This webinar was sponsored by the Justice Community Opioid Innovation Network (JCOIN) at the National Institute on Drug Abuse (NIDA), in partnership with the American Academy of Addiction Psychiatry (AAAP), the Providers Clinical Support System (PCSS) and the Addiction Policy Forum.
- Kathryn Cates-Wessel, CEO, American Academy of Addiction Psychiatry
- John J. Mariani, MD, Associate Professor of Clinical Psychiatry, Division on Substance Use Disorders, Columbia University
- Tisha Wiley, PhD, Branch Chief, Associate Director for Justice Systems, NIDA
- Jessica Hulsey, Executive Director, Addiction Policy Forum
